An ever-increasing pharmacopoeia for the management of patients with bipolar disorder

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 13, 2000, Pages 19-25

  Nemeroff, C B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; CONTRACEPTIVE AGENT; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; LITHIUM CITRATE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

AFFECTIVE NEUROSIS; ARTICLE; CLINICAL TRIAL; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL LITERATURE; MONOTHERAPY; NAUSEA; NEUROTOXICITY; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RECURRENCE RISK; RECURRENT DISEASE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ACETIC ACIDS; AMINES; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CARBAMAZEPINE; CLOZAPINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; ELECTROMAGNETICS; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LITHIUM; PIRENZEPINE; RISPERIDONE; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 0034533694     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania
2. Predictors of response to divalproex and lithium
3. Lithium therapy: Limitations and alternatives in the treatment in bipolar disorders
4. Predictors of response to mood stabilizers
5. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders
6. Predictors of valproate response in bipolar rapid cycling
7. Depression during mania: Treatment response to lithium or divalproex
8. The manic syndrome: Factors which may predict a patient's response to lithium, carbamazepine and valproate
9. Valproate oral loading in the treatment of acute mania
10. Intravenous valproate loading in acutely manic and depressed bipolar I patients
11. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients
12. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy
13. Weight gain in epileptic patients during treatment with valproic acid: A retrospective study
14. Is valproate pharmacotherapy associated with polycystic ovaries?
15. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy
16. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy
17. Pregnancy and breast-feeding: What psychiatrists need to know
18. Carbamazepine
19. Lithium and the anticonvulsants in the treatment of bipolar disorder
20. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness
21. Lamotrigine treatment of rapid cycling bipolar disorder
22. An open study of lamotrigine in refractory bipolar depression
23. Clinical studies on the use of lamotrigine in bipolar disorder
24. Spectrum on activity of lamotrigine in treatment-refractory bipolar disorder
25. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder
26. A double blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
27. Mood stabilization with lamotrigine in rapid-cycling bipolar disorder: A double-blind, placebo-controlled study
28. Gabapentin and lamotrigine in bipolar disorder
29. Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients
30. Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy
31. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder
32. An open label study of gabapentin in the treatment of acute mania
33. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: Results of an open-label study
34. Gabapentin as an adjunctive treatment in bipolar disorder
35. Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology
36. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states
37. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment
38. Gabapentin: A review of published experience in the treatment of bipolar disorder and other psychiatric conditions
39. Mood stabilization and weight loss with topiramate
40. Topiramate: New Preparation. Helpful in refractory partial epilepsy
41. Use of topiramate, a new anti-epileptic as a mood stabilizer
42. Open-label adjunctive topiramate in the treatment of bipolar disorders
43. Topiramate in severe treatment-refractory mania
44. Familial leukoencephalopathy in bipolar disorder
45. Structural changes in the brain of patients with bipolar affective disorder by MRI : A review of the literature
46. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia
47. Clinical and economic impact of newer versus older antipsychotic medications in a community mental health center
48. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia
49. Cost effectiveness of clozapine in patients with high and low levels of hospital use
50. Is clozapine a mood stabilizer?
51. Clozapine for treatment-refractory mania
52. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania
53. Response to clozapine in acute mania is more rapid than that of chlorpromazine
54. Long-term risperidone treatment in bipolar disorder: 6-month follow-up
55. Risperidone-induced mania
56. Mania induced by risperidone: Dose related?
57. Induction of mania by risperidone resistant to mood stabilizers
58. 2A receptor blockade
59. Olanzapine versus placebo in the treatment of acute mania
60. Olanzapine in treatment-resistant bipolar disorder
61. Olanzapine-induced mania
62. Hypomania-like syndrome induced by olanzapine
63. Olanzapine-induced psychotic mania in bipolar schizo-affective disorder
64. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment
65. Olanzapine-induced ketoacidosis with diabetes mellitus
66. Diabetic ketoacidosis with olanzapine treatment
67. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood
68. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe
69. Euphoric mania and rapid transcranial magnetic stimulation
70. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients
71. Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia
72. The efficacy of ECT in mixed affective states
73. Suicide and bipolar disorder
74. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression
75. Lamotrigine in the treatment of bipolar depression